Blood test clues for schizophrenia?
NCT ID NCT07434388
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study measured levels of two proteins, LRFN5 and OLFM4, in the blood of 60 people — some with schizophrenia and some healthy. The goal was to see if these markers are linked to symptoms and inflammation. The study was observational, meaning it did not test any treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new ways to understand or diagnose schizophrenia by measuring these blood markers.
- What could go wrong
- This was a small, observational study that only looked at blood levels at one time point. It does not test any treatment, so it cannot directly lead to a therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Elazığ Mental Health and Diseases Hospital Psychiatry Clinic
Elâzığ, Elâzığ, 23200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo help teens with severe mental illness?
- Blood test may spot schizophrenia early and guide treatment
- Could a broccoli compound help schizophrenia symptoms?
- Zapping the brain to ease Schizophrenia's 'Negative' symptoms?
- Could a gentle brain ZAP sharpen minds in schizophrenia?
- New schizophrenia drug shows promise in early brain study